The utilization of nanotechnology in medicine may fundamentally improve drug treatments for HIV patients, analysts at the University of Liverpool recommend in an investigation.
Nanotechnology is the control of issue on an atomic, molecular, and supramolecular scale, and can be applied in the medical field as nanomedicine. The study’s authors state this advancing control can possibly fundamentally improve HIV treatment.
“The fruits of our interdisciplinary research are beginning to be realized,” researcher Andrew Owen said in a press release. “Our approach has the potential to overcome challenges with current antiretroviral therapy, which include administration of high doses needed to achieve efficacious concentrations in the body, and the urgent need for better formulations for children living with HIV.”
During the study, specialists concentrated on the advancement of new oral therapies including the Solid Drug Nanoparticle technology. The methodology is intended to improve drug absorption into the body, lessening the dose and the expense of the operation. They were likewise ready to build up a novel water dispersible nanotherapy, which would evacuate the utilization of alcohol in pediatric medicine. The discoveries were published in the journal Nature Communications.
“The wide applicability of our strategy has implications for multiple therapy development programs and we are actively engaged in the creation of nanomedicine options to impact a range of clinical needs,” professor Steve Rannard added.
Specialists found that HIV patient groups have a strong ability to change to nanomedicine if advantages can be appeared.
